Genus (Animal Genetic) Overview

  • Founded
  • 1994
Founded
  • Status
  • Public
  • Employees
  • 170
Employees
  • Stock Symbol
  • GNS
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $33.57
  • (As of Tuesday Closing)

Genus (Animal Genetic) General Information

Description

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. The company generates most of its revenue from its porcine exposure, followed by its bovine exposure. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Contact Information

Website
www.genusplc.com
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Animal Husbandry
Stock Exchange
LON
Primary Office
  • Matrix House
  • Basing View
  • Basingstoke RG21 4DZ
  • England, United Kingdom
+44 01256 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genus (Animal Genetic) Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$33.57 $33.44 $26.94 - $87.32 $2.2B 65.8M 127K

Genus (Animal Genetic) Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019
EV 4,534,203 4,612,663 2,976,128 2,298,205
Revenue 772,189 694,275 632,166
EBITDA 127,735 110,802 53,705
Net Income 63,598 44,447 10,094
Total Assets 1,209,545 1,177,789 1,052,904 1,008,123
Total Debt 255,351 209,815 177,125 139,528
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genus (Animal Genetic) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genus (Animal Genetic)‘s full profile, request access.

Request a free trial

Genus (Animal Genetic) Patents

  • 17

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Genus (Animal Genetic) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210348165-A1 Methods for improving the health of porcine species by targeted inactivation of cd163 Pending 05-May-2020 00000000000
GB-201300065-D0 The cleaning of body parts Ceased 03-Jan-2013 0000000000
CA-2898875-A1 The cleaning of animal body parts Abandoned 03-Jan-2013 0000000000
US-20150351366-A1 The cleaning of animal body parts Granted 03-Jan-2013 0000000000 0
US-10080345-B2 Cleaning of animal body parts Active 03-Jan-2013 A01K13/001 0
To view Genus (Animal Genetic)’s complete patent history, request access »

Genus (Animal Genetic) Executive Team (9)

Name Title Board Seat Contact Info
Stephen Wilson Chief Executive Officer & Board Member
Alison Henriksen Chief Financial Officer, Finance & Board Member
Bill Christianson Chief Operating Officer
Elena Rice Ph.D Chief Scientific Officer
Mark Birri Director, Strategy and Business Development
You’re viewing 5 of 9 executive team members. Get the full list »

Genus (Animal Genetic) Board Members (9)

Name Representing Role Since
000000 000000000 Genus (Animal Genetic) Chief Financial Officer, Finance & Board Member 000 0000
0000 00000000 Genus (Animal Genetic) Chairman & Board Member 000 0000
000000 0000 Self Director 000 0000
000000 000 000 00000 Genus (Animal Genetic) Director 000 0000
0000000 0000 Genus (Animal Genetic) Director 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Genus (Animal Genetic) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genus (Animal Genetic) Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 02-Mar-2021 00000 0000 00.000 Biotechnology
000000000 31-Mar-2017 0000000000 Animal Husbandry 00000 000
00 00000 0000 31-Mar-2015 0000000000 00.000 Biotechnology 00000 000
0000000000 00 18-Oct-2013 0000000000 000.00 Other Commercial Services 00000 000
ABS Global 10-Dec-1999 Merger/Acquisition Animal Husbandry
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Genus (Animal Genetic) Subsidiaries (4)

Company Name Industry Location Founded
In Vitro Brasil Biotechnology Mogi Mirim, Brazil 2002
000 00000000000 00 Animal Husbandry Basingstoke, United Kingdom 0000
000000000 Animal Husbandry Kilkenny, Ireland 0000
000 000000 Animal Husbandry DeForest, WI 0000
To view Genus (Animal Genetic)’s complete subsidiaries history, request access »

Genus (Animal Genetic) Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 00000 01-Jan-1999 000000000000000000 Completed
  • 00000 (000000 0000
To view Genus (Animal Genetic)’s complete exits history, request access »